High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV. (Q54583647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

C Marchetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A Di Carlo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

F Facchiano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

C Senatore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

R De Cristofaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A Luzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Romani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Napolitano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M C Capogrossi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A Germani

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

8 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

236-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21656024%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-011-2213-6

3 February 2020

exact match

0 references

cites work

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

HMGB1: endogenous danger signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

High mobility group 1 B-box mediates activation of human endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Active Sequences Collection (ASC) database: a new tool to assign functions to protein sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

DPP4 inhibitors for diabetes--what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2213-6

High-Mobility Group Box 1 Protein in Human and Murine Skin: Involvement in Wound Healing

21 January 2018

1 reference

12 December 2020

Molecular characterization of dipeptidyl peptidase activity in serum

1 reference

12 December 2020

Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration

1 reference

12 December 2020

Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension

1 reference

12 December 2020

Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential

1 reference

12 December 2020

Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose

1 reference

12 December 2020